Artificial intelligence: A transformative tool in precision oncology

Jeremy McGale, Matthew J. Liao, Egesta Lopci, Aurélien Marabelle, Laurent Dercle

Research output: Contribution to journalReview articlepeer-review

Abstract

Artificial intelligence (AI) is revolutionizing society and healthcare, offering new possibilities for precision medicine. Immunotherapy in oncology (IO) has similarly transformed cancer treatment through novel mechanisms of therapeutic action, but has also led to atypical response patterns that challenge traditional methods for response evaluation. This editorial explores the role of AI in addressing these challenges through the development of new biomarkers for precise disease characterization, and in particular those built on imaging for the early response assessment of patients diagnosed with cancer and treated with IO. Properly leveraged AI-based techniques could herald a new era of precision medicine guided by non-invasive, imaging-based disease evaluation.

Original languageEnglish
Pages (from-to)588-589
Number of pages2
JournalOncotarget
Volume15
DOIs
Publication statusPublished - 1 Jan 2024
Externally publishedYes

Keywords

  • CT
  • MRI
  • PET
  • SPECT
  • artificial intelligence
  • immunotherapy
  • lactate dehydrogenase
  • oncology
  • radiomics

Cite this